Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.7 EUR | -1.27% | -2.09% | -8.24% |
03-14 | Hyloris Pharmaceuticals SA Provides Earnings Guidance for 2024 | CI |
03-14 | Transcript : Hyloris Pharmaceuticals SA, 2023 Earnings Call, Mar 14, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-8.24% | 350M | |
+33.02% | 704B | |
+28.59% | 577B | |
-3.71% | 348B | |
+18.25% | 327B | |
+4.72% | 288B | |
+14.81% | 234B | |
+4.93% | 198B | |
-9.78% | 194B | |
-4.28% | 147B |
- Stock Market
- Equities
- HYL Stock
- News Hyloris Pharmaceuticals SA
- Hyloris Pharmaceuticals Receives US FDA Request For Additional Information On Maxigesic